Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine

Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine

We used Neuromolecular Imaging (NMI) and trademarked BRODERICK PROBE® mini-implantable biosensors, to selectively and separately detect neurotransmitters in vivo, on line, within seconds in the dorsal striatal brain of the Parkinson’s Disease (PD) animal model. We directly compared our results deriv...

Full description

Bibliographic Details
Main Authors:	Patricia A. Broderick, Edwin H. Kolodny
Format:	Article
Language:	English
Published:	MDPI AG 2009-12-01
Series:	Pharmaceuticals
Subjects:	biomarkers biosensors Parkinson’s disease neuromolecular imaging electrochemistry neurotransmitters monoamines dopamine serotonin peptides dynorphin A somatostatin basal ganglia brain neurons dorsal striatum movement disorders substantia nigra nigrostriatal pathways
Online Access:	http://www.mdpi.com/1424-8247/2/3/236/

Similar Items

Beyond reward prediction errors: the role of dopamine in movement kinematics
by: Joseph eBarter, et al.
Published: (2015-05-01)

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
by: Patricia Tagliaferro, et al.
Published: (2015-10-01)

Extrastriatal dopaminergic circuits of the basal ganglia
by: Karen Suzanne Rommelfanger, et al.
Published: (2010-10-01)

Midbrain dopaminergic neurons generate calcium and sodium currents and release dopamine in the striatum of pups
by: Diana Carolina Ferrari, et al.
Published: (2012-03-01)

Glutamate-induced reversal of dopamine transport is mediated by the PKC signalling pathway
by: Opazo Dávila, Luis Felipe
Published: (2009)

Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity
by: Saskia Kücker, et al.
Published: (2010-03-01)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
by: Allen PF Chen, et al.
Published: (2021-06-01)

To dopamine and beyond, a review of the mechanisms of Parkinson's disease
by: Chester, Andrew
Published: (2018)

Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice
by: Heather A. Boger, et al.
Published: (2009-03-01)

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
by: Alison L. McCormack, et al.
Published: (2002-07-01)

Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective
by: Anders Björklund, et al.
Published: (2020-05-01)

In Vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-length (YAC128) Transgenic Mouse Models of Huntington’s Disease
by: Joshua W Callahan, et al.
Published: (2011-07-01)

Continuous bilateral infusion of vigabatrin into the subthalamic nucleus: Effects on seizure threshold and GABA metabolism in two rat models
by: Laura Gey, et al.
Published: (2016-07-01)

Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine.
by: Kristen Ashley eHorner, et al.
Published: (2011-05-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice
by: Å. Petersén, et al.
Published: (2002-10-01)

Allopregnanolone and Neurogenesis in the Nigrostriatal Tract
by: Junming eWang
Published: (2014-08-01)

Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
by: Sacnité Albarrán-Bravo, et al.
Published: (2019-09-01)

Separate groups of dopamine neurons innervate caudate head and tail encoding flexible and stable value memories
by: Hyoung F Kim, et al.
Published: (2014-10-01)

A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans
by: Alberto Cacciola, et al.
Published: (2016-07-01)

Synaptic Plasticity in Basal Ganglia Output Neurons in Parkinson's Disease Patients
by: Prescott, Ian
Published: (2009)

Synaptic Plasticity in Basal Ganglia Output Neurons in Parkinson's Disease Patients
by: Prescott, Ian
Published: (2009)

Vigabatrin for focal drug delivery in epilepsy: Bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model
by: Sonja Bröer, et al.
Published: (2012-05-01)

Deep brain stimulation changes basal ganglia output nuclei firing pattern in the dystonic hamster
by: Arthur Leblois, et al.
Published: (2010-05-01)

Interactions between the midbrain superior colliculus and the basal ganglia
by: Peter eRedgrave, et al.
Published: (2010-09-01)

Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area
by: Billy T Chen, et al.
Published: (2011-06-01)

Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress
by: Rasem Mustafa, et al.
Published: (2021-08-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

Pup suckling is more rewarding than cocaine: evidence from functional magnetic resonance imaging and three-dimensional computational analysis
by: Harder, Josie A., et al.
Published: (2009)

Developmental Characterization of Schizophrenia-Associated Gene Zswim6 in Mouse Forebrain
by: Chuan-Chie Chang, et al.
Published: (2021-05-01)

Corrigendum: Morphological evidence for dopamine interactions with pallidal neurons in primates
by: Lara eEid, et al.
Published: (2015-09-01)

Morphological evidence for dopamine interactions with pallidal neurons in primates
by: Lara eEid, et al.
Published: (2015-08-01)

Glutamatergic pallidothalamic projections and their implications in the pathophysiology of Parkinson’s disease
by: Pedro Barroso-Chinea, et al.
Published: (2008-09-01)

Selective Knockout of the Vesicular Monoamine Transporter 2 (Vmat2) Gene in Calbindin2/Calretinin-Positive Neurons Results in Profound Changes in Behavior and Response to Drugs of Abuse
by: Niclas König, et al.
Published: (2020-11-01)

Habitual Behavior and Dopamine Cell Vulnerability in Parkinson´s Disease
by: Ledia eF. Hernandez, et al.
Published: (2015-08-01)

Electrochemical Biosensing of Dopamine Neurotransmitter: A Review
by: Sophie Lakard, et al.
Published: (2021-06-01)

5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease
by: Erwan Bezard, et al.
Published: (2006-07-01)

Parsing Heterogeneous Striatal Activity
by: Kae Nakamura, et al.
Published: (2017-05-01)

Functional properties of striatal fast-spiking interneurons
by: Joshua D Berke
Published: (2011-06-01)

The Michelin Red Guide of the Brain: role of Dopamine in Goal-oriented Navigation
by: Aude eRetailleau, et al.
Published: (2014-03-01)